Opioid-Sparing Protocols Cut Postoperative Pain Medication Use

A systematic review published in Discover Medicine reports that the implementation of opioid-sparing protocols, specifically Enhanced Recovery After Surgery (ERAS) and multimodal analgesia, is associated with significant reductions in postoperative opioid consumption across cardiac, orthopedic, and gynecological surgical specialties. The study, led by Mahnoor Amjad and colleagues, analyzed data from 17 peer-reviewed studies involving a total cohort of 13,529 patients. The research aimed to evaluate how these innovative pain management strategies influence patient recovery and opioid prescribing trends following post-operative procedures. By synthesizing data from studies published between January 2021 and April 2026, the review provides a contemporary overview of clinical practices designed to minimize reliance on traditional opioid analgesics while maintaining adequate pain control.

The primary objective of the review was to analyze opioid consumption rates after the introduction of these opioid-sparing protocols and to assess their impact on patient recovery. The authors utilized the Preferred Reporting Items for Systematic Review and Meta-analysis (PRISMA) guidelines to ensure rigorous methodology. The literature search was conducted across Cochrane, PubMed, Wiley Online Library, and Google Scholar, focusing on adult populations in the three specified surgical domains. The study excluded patients who had used opioids prior to surgery to prevent confounding variables and focused on observational studies that reflect real-world clinical implementation rather than artificially designed interventions.

Morphine Milligram Equivalents (MME) served as the standardized quantitative measure for comparing the potency of different opioids to that of oral morphine. MME is calculated by multiplying the opioid dosage strength, the equianalgesic conversion factor, and the quantity of opioids prescribed. This metric allows for a consistent comparison of opioid usage across different surgical procedures and patient populations. The review found that the integration of ERAS and multimodal analgesia therapy was consistently associated with a decrease in MME across all three surgical specialties, indicating a shift away from conventional opioid-heavy prescribing practices.

In the gynecological and obstetric domain, the review included eight studies involving 9,417 patients undergoing cesarean sections. These studies demonstrated the most consistent patterns of MME reduction. One cohort observed a 78.1% drop in MME, decreasing from 128 to 28 MME by post-operative day 2. Another study reported a more modest 5% reduction, from 40 to 30 MME by post-operative day 1. Notably, one cohort achieved an entirely opioid-free recovery by post-operative day 2. In the largest obstetric study, which included 4,903 patients, simultaneous reductions were noted in both inpatient and discharge MME, with values falling from 75 to 30 MME and 225 to 112.5 MME, respectively. Six of the eight studies recorded an MME reduction of more than 50%.

Cardiac surgery cohorts, comprising six studies with a total of 3,241 patients, also showed significant decreases in post-operative MME demand. Procedures included elective sternotomy, coronary artery bypass grafting, and heart transplantation. Following the implementation of ERAS society-certified protocols for elective sternotomy, patients showed a 75% reduction in analgesic requirement by post-operative day 2, dropping from 12 to 3 MME. A parallel study at the same center confirmed this outcome, noting a drop from 9.90 to 3.30 MME. In adult cohorts undergoing coronary artery bypass grafting and valve surgery, opioid requirements fell by 79% by post-operative day 1. For heart transplant and left ventricular assist device populations, the introduction of ERAS pathways led to a decrease in daily average MME from 78 to 26.25, allowing physicians to bypass opioid prescribing upon patient discharge.

Orthopedic studies, which included three investigations involving 871 patients undergoing total joint arthroplasty and total knee arthroplasty, exhibited the most definitive absolute MME reductions. The most substantial absolute decrease was recorded in a total knee arthroplasty cohort, where the mean MME fell from 169.5 to 66.7, representing a 60.6% reduction. In the largest orthopedic investigation, a multidisciplinary protocol involving pharmacists, nurses, and surgeons facilitated a reduction from 84.7 to 57.0 MME by post-operative day 1. A single-center study in China documented a decline from 52.4 to 39.6 MME at post-operative day 2, demonstrating that the efficacy of these protocols extends beyond Western healthcare contexts.

Secondary outcomes focused on patient-related metrics, including post-operative pain scores and length of hospital stay. In cardiac care, discomfort remained under the standard limit of four on numerical scales post-certification, with other studies reporting drops from 4.85 to 4.15 and 1.12 to 0.89. Among cesarean patients, multimodal plans shifted outcomes from moderate discomfort to virtually none, with one study finding a significant decrease from 3.4 to 2.9 during hospitalization. Orthopedic results were particularly striking, with pain scores falling from 5.2 to 2.1 by the first day in one study and from 4.7 to 4.1 in another using multimodal methods. These findings suggest that reduced opioid use is not associated with reduced analgesia or increased pain perception.

Length of stay also showed a marked downward trend under the implementation of opioid-sparing practices. In cardiac care, hospital stay decreased from 11 to 9 days in one study, although one investigation noted an unexpected increase from 10.4 to 11.2 days, potentially due to more cautious discharge criteria. In the orthopedic sector, the most significant gains were observed, with length of stay decreasing from 9.0 to 7.3 days in one study and from 66.8 to 22.3 hours, a 66.6% decrease, in another. For the cesarean group, adherence to multimodal protocols led to notable improvements, with one mixed-specialty group reporting a drop from 3.0 to 2.1 days.

The review highlights that the effectiveness of opioid-sparing analgesic protocols is evident in their ability to optimize recovery outcomes while lessening opioid-related harms. Instead of relying solely on opioid dosing, these new practices act on multiple nociceptive pathways through agents such as acetaminophen, gabapentinoids, and dexamethasone. The data demonstrates a paradigm shift across gynecological, orthopedic, and cardiac surgeries towards opioid-sparing analgesic and ERAS therapy. This shift is driven by universal opioid stewardship proactivity and increased awareness of the risks regarding opioid use disorder among prescribers. The synchronous examination of three surgical specialties within a single consolidated model provides a comprehensive view of the predictors of opioid use from a broader system-level perspective.

Limitations of the study include the absence of a meta-analysis due to diverse endpoints and substantial heterogeneity in comparable factors. The review also noted the adoption of Cochrane CENTRAL instead of EMBASE, which is more focused on randomized controlled trials. Confounding elements such as diverse patient-specific baseline characteristics, including body mass index, pre-existing opioid exposure, and altered baseline pain thresholds, restricted the feasibility of covariate-adjusted comparisons. Additionally, there was underreporting of post-surgical pain in some orthopedic studies, highlighting the widespread scarcity of standardized guidelines in opioid-sparing research. Despite these limitations, the review provides valuable insights into current clinical prescribing trends and the potential benefits of opioid-sparing protocols in reducing postoperative opioid exposure.

The findings underscore the vital role of minimizing traditional patterns of opioid prescribing to decrease the risk of opioid use disorder globally. By integrating standardized, multimodal frameworks, healthcare systems can successfully reduce post-surgical opioid exposure while safeguarding patient well-being. The review suggests that procedure- and specialty-specific prescribing standards predicated on actual consumption, rather than prescription counts, can bridge the evidence-to-implementation gap. This approach is particularly important given the global disparities in opioid-sparing analgesic techniques between upper-middle-income countries and high-income countries. The evidence supports the pervasive adoption of opioid-sparing analgesic protocols, mainly ERAS- and multimodal-based analgesic therapies, across these surgical specialties to address the challenge of extensive opioid prescribing.

Subject of Research: Impact of opioid-sparing protocols on postoperative prescribing patterns and patient outcomes

Article Title: A systematic review to evaluate postoperative prescribing patterns and impact of opioid sparing protocols across multiple surgical specialties

Article References: Amjad, M., Qayyum, M., Nawaz, B., & Khalid, H. M. O. (2026). A systematic review to evaluate postoperative prescribing patterns and impact of opioid sparing protocols across multiple surgical specialties. Discover Medicine, 3(1), Article 139. https://doi.org/10.1007/s44337-026-00704-7

Image Credits: AI Generated

DOI: 10.1007/s44337-026-00704-7

Keywords: opioid-sparing protocols, postoperative pain, ERAS, multimodal analgesia, MME, surgical recovery, cardiac surgery, orthopedic surgery, gynecological surgery, systematic review, systematic, review